Ladenburg Thalmann Downgrades F-Star Therapeutics Inc. (FSTX) to Neutral
Tweet
Share
E-mailGet Alerts FSTX Hot Sheet
Price: $7.12 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ladenburg Thalmann analyst Ahu Demir downgraded F-Star Therapeutics Inc. (NASDAQ: FSTX) from Buy to Neutral.
For an analyst ratings summary and ratings history on F-Star Therapeutics Inc. click here. For more ratings news on F-Star Therapeutics Inc. click here.
Shares of F-Star Therapeutics Inc. closed at $3.98 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- JPMorgan Downgrades KinderCare Learning Companies (KLC) to Underweight
- Wolfe Research Downgrades T-Mobile (TMUS) to Peerperform
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
